FR2260565A1 - - Google Patents

Info

Publication number
FR2260565A1
FR2260565A1 FR7504160A FR7504160A FR2260565A1 FR 2260565 A1 FR2260565 A1 FR 2260565A1 FR 7504160 A FR7504160 A FR 7504160A FR 7504160 A FR7504160 A FR 7504160A FR 2260565 A1 FR2260565 A1 FR 2260565A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7504160A
Other languages
French (fr)
Other versions
FR2260565B1 (US07585860-20090908-C00150.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Armour Pharmaceutical Co
Original Assignee
Armour Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharmaceutical Co filed Critical Armour Pharmaceutical Co
Publication of FR2260565A1 publication Critical patent/FR2260565A1/fr
Application granted granted Critical
Publication of FR2260565B1 publication Critical patent/FR2260565B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08HDERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00Macromolecular products derived from proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/30Introducing nitrogen atoms or nitrogen-containing groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/28Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7504160A 1974-02-12 1975-02-11 Expired FR2260565B1 (US07585860-20090908-C00150.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US441770A US3915949A (en) 1974-02-12 1974-02-12 Solid phase synthesis of ACTH

Publications (2)

Publication Number Publication Date
FR2260565A1 true FR2260565A1 (US07585860-20090908-C00150.png) 1975-09-05
FR2260565B1 FR2260565B1 (US07585860-20090908-C00150.png) 1978-07-13

Family

ID=23754214

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7504160A Expired FR2260565B1 (US07585860-20090908-C00150.png) 1974-02-12 1975-02-11

Country Status (14)

Country Link
US (1) US3915949A (US07585860-20090908-C00150.png)
JP (1) JPS5850982B2 (US07585860-20090908-C00150.png)
AU (1) AU503998B2 (US07585860-20090908-C00150.png)
BE (1) BE825397A (US07585860-20090908-C00150.png)
CA (1) CA1062249A (US07585860-20090908-C00150.png)
DE (1) DE2505712A1 (US07585860-20090908-C00150.png)
DK (1) DK51675A (US07585860-20090908-C00150.png)
ES (1) ES434673A1 (US07585860-20090908-C00150.png)
FR (1) FR2260565B1 (US07585860-20090908-C00150.png)
GB (2) GB1508682A (US07585860-20090908-C00150.png)
NL (1) NL7501666A (US07585860-20090908-C00150.png)
NO (2) NO148332C (US07585860-20090908-C00150.png)
SE (1) SE7501342L (US07585860-20090908-C00150.png)
ZA (1) ZA75880B (US07585860-20090908-C00150.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362120A1 (fr) * 1976-02-13 1978-03-17 Armour Pharma Peptides et procede de synthese
FR2389599A1 (US07585860-20090908-C00150.png) * 1977-05-02 1978-12-01 Armour Pharma

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130514A (en) * 1978-02-10 1978-12-19 Armour Pharmaceutical Company Synthesis of peptides
SE447263B (sv) * 1979-04-20 1986-11-03 Bonnierfoeretagen Ab Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid
US4336187A (en) * 1979-11-14 1982-06-22 Armour Pharmaceutical Company Purification of calcitonin by partition chromatography
US4487715A (en) * 1982-07-09 1984-12-11 The Regents Of The University Of California Method of conjugating oligopeptides
IT1204434B (it) * 1986-01-15 1989-03-01 Alfio Bertolini Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
CN103665147A (zh) * 2013-11-26 2014-03-26 深圳翰宇药业股份有限公司 一种生长激素释放因子衍生物的合成方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362120A1 (fr) * 1976-02-13 1978-03-17 Armour Pharma Peptides et procede de synthese
FR2389599A1 (US07585860-20090908-C00150.png) * 1977-05-02 1978-12-01 Armour Pharma

Also Published As

Publication number Publication date
NO750409L (US07585860-20090908-C00150.png) 1975-08-13
US3915949A (en) 1975-10-28
BE825397A (fr) 1975-05-29
DE2505712A1 (de) 1975-08-28
NL7501666A (nl) 1975-08-14
JPS5850982B2 (ja) 1983-11-14
SE7501342L (US07585860-20090908-C00150.png) 1975-08-13
GB1508681A (en) 1978-04-26
NO148373B (no) 1983-06-20
NO148332C (no) 1983-09-21
ZA75880B (en) 1976-01-28
GB1508682A (en) 1978-04-26
AU7796775A (en) 1976-08-12
NO148332B (no) 1983-06-13
CA1062249A (en) 1979-09-11
NO812168L (no) 1975-08-13
JPS50129557A (US07585860-20090908-C00150.png) 1975-10-13
DK51675A (US07585860-20090908-C00150.png) 1975-10-06
NO148373C (no) 1983-09-28
FR2260565B1 (US07585860-20090908-C00150.png) 1978-07-13
ES434673A1 (es) 1977-08-16
AU503998B2 (en) 1979-09-27

Similar Documents

Publication Publication Date Title
FR2280140B1 (US07585860-20090908-C00150.png)
FR2260616B1 (US07585860-20090908-C00150.png)
FI752728A (US07585860-20090908-C00150.png)
FR2294993B1 (US07585860-20090908-C00150.png)
FR2260565B1 (US07585860-20090908-C00150.png)
FR2267450A1 (US07585860-20090908-C00150.png)
JPS50102230A (US07585860-20090908-C00150.png)
FR2269405B3 (US07585860-20090908-C00150.png)
FR2293886B1 (US07585860-20090908-C00150.png)
FR2276430B1 (US07585860-20090908-C00150.png)
FR2259489B3 (US07585860-20090908-C00150.png)
FR2279392B1 (US07585860-20090908-C00150.png)
JPS50103878A (US07585860-20090908-C00150.png)
CH562462A5 (US07585860-20090908-C00150.png)
CH1163975A4 (US07585860-20090908-C00150.png)
BG20854A1 (US07585860-20090908-C00150.png)
CH562521A5 (US07585860-20090908-C00150.png)
BG22571A1 (US07585860-20090908-C00150.png)
BG22061A3 (US07585860-20090908-C00150.png)
BG23065A1 (US07585860-20090908-C00150.png)
BG21634A1 (US07585860-20090908-C00150.png)
BG20883A1 (US07585860-20090908-C00150.png)
CH1703874A4 (US07585860-20090908-C00150.png)
CH1727074A4 (US07585860-20090908-C00150.png)
BG22586A1 (US07585860-20090908-C00150.png)

Legal Events

Date Code Title Description
ST Notification of lapse